Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Payments to Acquire Marketable Securities	$ 10.4	$ 0.1
Proceeds from (Payments to) Noncontrolling Interests	(15.8)	(0.3)
Operating Activities
Net income	237.1	256.9
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	125.2	120.4
Impairment charges	0.1	0.8
Loss on sale of assets	1.7	(1.0)
Deferred income tax provision	(6.7)	1.7
Stock-based compensation expense	19.2	20.7
Pension and other postretirement expense	(3.9)	(23.2)
Pension contributions and other postretirement benefit payments	12.9	37.1
Changes in operating assets and liabilities:
Accounts receivable	(27.6)	(6.4)
Increase (Decrease) in Contract with Customer, Asset	11.9	35.0
Inventories	47.9	37.8
Accounts payable, trade	(2.8)	7.4
Other accrued expenses	(49.4)	28.7
Income taxes	(12.4)	(9.0)
Other, net	24.4	(0.1)
Net Cash Provided by Operating Activities	457.2	354.8
Investing Activities
Capital expenditures	85.7	82.9
Acquisitions, net of cash received	6.7	82.7
Other	1.4	3.3
Net Cash Used by Investing Activities	(101.4)	(162.2)
Financing Activities
Cash dividends paid to shareholders	(65.0)	(63.8)
Purchase of treasury shares	(42.3)	(56.1)
Assets for Plan Benefits, Defined Benefit Plan	18.2	9.9
Payment, Tax Withholding, Share-based Payment Arrangement	12.0	9.3
Proceeds from Accounts Receivable Securitization	10.0	25.0
Repayments of Accounts Receivable Securitization	110.0	0.0
Proceeds from Issuance of Long-term Debt	550.0	451.0
Payments on long-term debt	(635.2)	(481.7)
Payments of Financing Costs	1.6	1.9
Short-term debt activity, net	46.0	(10.2)
Net Cash Used by Financing Activities	(257.7)	(137.4)
Effect of exchange rate changes on cash	(0.3)	(6.4)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	97.8	48.8
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 314.0	$ 181.9